Z. Sirotovà

Salvage Treatment with Epirubicin and/or Paclitaxel in Metastatic Breast Cancer Patients Relapsed after High-dose Chemotherapy with Peripheral Blood Progenitor Cells

M. Aieta, A. Tartarone, G. Lelli, 2001, Tumori.

Evaluation of Bone Metastases by 18F-Choline PET/CT in a Patient with Castration-Resistant Prostate Cancer Treated with Radium-223

C. Baiocco, S. Genovese, C. Poti, 2017, Urologia.

Hospital Admission of Cancer Patients: Avoidable Practice or Necessary Care?

Antonio Trogu, Gianmauro Numico, P. Franco, 2015, PloS one.

First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry

S. Conforti, G. Di Lorenzo, S. Rossetti, 2022, Tumori.

Combination of Paclitaxel and Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer: A Phase I-II Study

A. Simeone, B. Rinaldi, F. Morelli, 2001, Journal of chemotherapy.

13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group.

G. Margarino, M. Benazzo, S. Gandolfo, 2004, Oncology reports.

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

D. Katsaros, L. Cavanna, I. Meinhold-Heerlein, 2023, British Journal of Cancer.